ClearPoint Neuro Inc (CLPT)
11.84
+0.74
(+6.72%)
USD |
NASDAQ |
Nov 22, 16:00
11.83
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Cash from Operations (Quarterly): -1.199M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.199M |
June 30, 2024 | -2.668M |
March 31, 2024 | -3.84M |
December 31, 2023 | -1.169M |
September 30, 2023 | -1.796M |
June 30, 2023 | -5.075M |
March 31, 2023 | -5.68M |
December 31, 2022 | -3.065M |
September 30, 2022 | -3.852M |
June 30, 2022 | -4.981M |
March 31, 2022 | -4.269M |
December 31, 2021 | -3.552M |
September 30, 2021 | -3.296M |
June 30, 2021 | -3.718M |
March 31, 2021 | -2.131M |
December 31, 2020 | -2.401M |
September 30, 2020 | -1.367M |
June 30, 2020 | -1.708M |
March 31, 2020 | -2.331M |
December 31, 2019 | -0.4663M |
September 30, 2019 | -0.9641M |
June 30, 2019 | -0.8101M |
March 31, 2019 | -0.6095M |
December 31, 2018 | -0.5824M |
September 30, 2018 | -0.9753M |
Date | Value |
---|---|
June 30, 2018 | -1.112M |
March 31, 2018 | -1.961M |
December 31, 2017 | -1.746M |
September 30, 2017 | -1.681M |
June 30, 2017 | -1.219M |
March 31, 2017 | -1.346M |
December 31, 2016 | -1.112M |
September 30, 2016 | -1.416M |
June 30, 2016 | -1.684M |
March 31, 2016 | -1.609M |
December 31, 2015 | -1.318M |
September 30, 2015 | -1.603M |
June 30, 2015 | -2.918M |
March 31, 2015 | -2.799M |
December 31, 2014 | -1.994M |
September 30, 2014 | -2.175M |
June 30, 2014 | -1.722M |
March 31, 2014 | -1.359M |
December 31, 2013 | -1.514M |
September 30, 2013 | -1.835M |
June 30, 2013 | -2.186M |
March 31, 2013 | -2.243M |
December 31, 2012 | -2.227M |
September 30, 2012 | -1.955M |
June 30, 2012 | -1.368M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.68M
Minimum
Mar 2023
-0.4663M
Maximum
Dec 2019
-2.928M
Average
-2.866M
Median
Cash from Operations (Quarterly) Benchmarks
Perspective Therapeutics Inc | 3.366M |
Retractable Technologies Inc | -5.727M |
InfuSystems Holdings Inc | 9.842M |
Xtant Medical Holdings Inc | -1.718M |
Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.012M |
Cash from Financing (Quarterly) | -10.06M |
Free Cash Flow | -9.076M |
Free Cash Flow Per Share (Quarterly) | -0.0439 |
Free Cash Flow to Equity (Quarterly) | 8.768M |
Free Cash Flow Yield | -2.92% |